TY - JOUR
KW - Adult
KW - Antiviral Agents/administration & dosage/therapeutic use
KW - Buprenorphine/administration & dosage/therapeutic use
KW - Directly Observed Therapy
KW - Drug Users
KW - Female
KW - Group treatment
KW - Hepacivirus
KW - Hepatitis C virus
KW - Hepatitis C, Chronic/drug therapy/virology
KW - Humans
KW - Informed Consent
KW - Injection drug use
KW - Male
KW - Medication Adherence
KW - Methadone/administration & dosage/therapeutic use
KW - models of care
KW - New York
KW - Opiate Substitution Treatment
KW - People who inject drugs
KW - Research Design
KW - Self Report
AU - M. J. Akiyama
AU - L. Agyemang
AU - J. H. Arnsten
AU - M. Heo
AU - B. L. Norton
AU - B. R. Schackman
AU - B. P. Linas
AU - A. H. Litwin
A1 - 
BT - BMC infectious diseases
C5 - Opioids & Substance Use
CP - 1
CY - England
DO - 10.1186/s12879-018-2964-5
IS - 1
JF - BMC infectious diseases
PP - England
PY - 2018
SN - 1471-2334; 1471-2334
SP - 74
T1 - Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
T2 - BMC infectious diseases
TI - Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
U1 - Opioids & Substance Use
U2 - 29426304
U3 - 10.1186/s12879-018-2964-5
VL - 18
VO - 1471-2334; 1471-2334
Y1 - 2018
ER -